Status:
COMPLETED
The FVC/DLCO Ratio is a Useful Predictor of Pulmonary Hypertension in Patients With Interstitial Lung Disease
Lead Sponsor:
Assiut University
Conditions:
Interstitial Lung Disease
Pulmonary Hypertension
Eligibility:
All Genders
Brief Summary
Pulmonary hypertension (PH) is a common disorder among patients with interstitial lung disease (ILD). The symptoms are usually nonspecific and overlooked. Thus, a noninvasive screening modality is rec...
Eligibility Criteria
Inclusion
- This retrospective study included all patients diagnosed with interstitial lung disease (ILD) who were followed up by the chest department of a tertiary hospital between September 2016 and January 2017
Exclusion
- patients with occupational history
- collagen vascular disease predisposing them to lung disorders
- patients who could not undergo pulmonary function testing
Key Trial Info
Start Date :
February 2 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2017
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT03396120
Start Date
February 2 2017
End Date
December 31 2017
Last Update
January 10 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
AssiutU
Asyut, Egypt, 71111
2
Pulmonology Departments
Asyut, Egypt, 71111